SCHEMBL186360

SCHEMBL186360

CCNc1ncc(OC(=O)O)cn1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
VNN1 O95497 7/20 0.40
HCAR3 P49019 1/20 0.40
ACACB O00763 5/20 0.39
PKM P14618 1/20 0.38
MAPK1 P28482 1/20 0.38
L3MBTL1 Q9Y468 3/20 0.37
CYP1A2 P05177 3/20 0.37
ALDH1A1 P00352 3/20 0.37
GLA P06280 2/20 0.37
CASP1 P29466 2/20 0.37
CASP7 P55210 2/20 0.37
HSD17B10 Q99714 2/20 0.37
MEN1 O00255 2/20 0.37
KMT2A Q03164 2/20 0.37
CYP3A4 P08684 1/20 0.37
ALOX15 P16050 1/20 0.37
CLK4 Q9HAZ1 1/20 0.37
CYP2C19 P33261 2/20 0.36
USP2 O75604 1/20 0.36
HPGD P15428 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL186223 0.86 HCAR3 (0.43) VNN1HCAR3ACACBALDH1A1HSD17B10
SCHEMBL16824294 0.80 HCAR3 (0.48) VNN1HCAR3ACACBMAPK1CYP1A2
SCHEMBL186008 0.79 GRM5 (0.39) VNN1HCAR3ACACBCYP1A2ALDH1A1
SCHEMBL10589105 0.76 CYP1A2 (0.41) MAPK1L3MBTL1CYP1A2ALDH1A1HSD17B10
SCHEMBL186657 0.76 KMT2A (0.34) CYP1A2ALDH1A1GLAHSD17B10MEN1
SCHEMBL186359 0.76 HCAR3 (0.61) VNN1HCAR3ACACBALDH1A1HSD17B10
SCHEMBL200701 0.75 HDAC3 (0.41) VNN1HCAR3ACACBPKMMAPK1
SCHEMBL186125 0.74 KMT2A (0.40) ACACBMAPK1L3MBTL1GLAKMT2A
SCHEMBL19609085 0.73 MAPK1 (0.49) VNN1HCAR3ACACBPKMMAPK1
SCHEMBL185620 0.72 LMNA (0.35) ALDH1A1GLAHSD17B10MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2401256-B1 Compounds as bradykinin B1 antagonists BOEHRINGER INGELHEIM INT (DE) 2013-04-17 EP disclosed
EP-2401256-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS Boehringer Ingelheim International GmbH (DE) 2012-01-04 EP disclosed
WO-2010097372-A1 COMPOUNDS AS BRADYKININ B1 ANTAGONISTS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2010-09-02 WO disclosed